BioCryst Pharma (BCRX) Reports In-Line Q3 EPS, Offers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq drops as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
BioCryst Reports Third Quarter 2015 Financial Results
November 5, 2015 6:55 AM ESTRESEARCH TRIANGLE PARK, N.C., Nov. 5, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced financial results for the third quarter ended September 30, 2015.
"The completion of enrollment of our OPuS-2 trial of avoralstat and the successful outcome... More
